Midwest Professional Planners Ltd (MPPL)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-11,106
Closed -$445K – 159
2024
Q3
$445K Buy
11,106
+966
+10% +$44.9K 0.14% 133
2024
Q2
$483K Buy
10,140
+424
+4% +$17.4K 0.16% 111
2024
Q1
$421K Buy
9,716
+1,197
+14% +$57.1K 0.15% 115
2023
Q4
$431K Buy
8,519
+694
+9% +$33.2K 0.17% 95
2023
Q3
$355K Buy
7,825
+1,232
+19% +$50.8K 0.16% 97
2023
Q2
$271K Buy
+6,593
New +$253K 0.12% 110

Other funds holding IONS

Midwest Professional Planners Ltd (MPPL)'s IONS Position: Q4 2024 in Review

Midwest Professional Planners Ltd (MPPL) sold out of Ionis Pharmaceuticals (IONS) in Q4 2024, closing a stake of 11,106 shares — an estimated $445K sold.

Midwest Professional Planners Ltd (MPPL) first reported a position in IONS in Q2 2023 and held it in 6 quarters. The position peaked at $483K in Q2 2024. 355 funds tracked by Wall St. Rank hold IONS as of Q4 2024.

  • Midwest Professional Planners Ltd (MPPL) reported no remaining Ionis Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Midwest Professional Planners Ltd (MPPL) sold 11,106 Ionis Pharmaceuticals shares in Q4 2024, an estimated $445K.
  • Midwest Professional Planners Ltd (MPPL) first reported a position in Ionis Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • Midwest Professional Planners Ltd (MPPL)'s Ionis Pharmaceuticals position peaked at $483K in Q2 2024.
  • 355 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2024.

Based on Midwest Professional Planners Ltd (MPPL)'s 13F filing for Q4 2024, filed 10 Feb 2025.